- |||||||||| Quviviq (daridorexant) / Idorsia, Mochida, Syneos Health, Sosei
New P1 trial: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects (clinicaltrials.gov) - Oct 22, 2015
P1, N=84, Recruiting,
- |||||||||| Quviviq (daridorexant) / Idorsia, Mochida, Syneos Health, Sosei
Enrollment open: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects (clinicaltrials.gov) - Oct 22, 2015
P1, N=84, Recruiting,
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
|
